# Mass Balance Study of [14C]-NT-814 Oral Suspension in Healthy Male Subjects

> **NCT04654897** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C]-NT-814

## Key facts

- **NCT ID:** NCT04654897
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-30
- **Primary completion:** 2020-10-29
- **Final completion:** 2020-10-29
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2021-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04654897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04654897, "Mass Balance Study of [14C]-NT-814 Oral Suspension in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04654897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*